Funnelfeedr Logo

DiaBridge AB

Sverige556979-7995Active

Developing breakthrough drugs targeting DNA repair for cancer and inflammation.

Biotechnology/Pharmaceutical Companyoxcia.com

Oversikt

0
Ansatte
0 SEK
Omsetning
2014
Grunnlagt

Nøkkelbeslutningstakere

Ulrika Warpman Berglund

CEO

@oxcia.com+46732XXXXXX

Monika Vedin

Business strategy & Communication Director

@oxcia.com

Christina Kalderén

Preclinical Director

@oxcia.com

Austin Smith

Chief Medical Officer

@oxcia.com

+5 flere kontakter i Funnelfeedr

Beskrivelse

Oxcia AB is a science-led Swedish biotechnology company focused on revolutionizing treatments for cancer and inflammation. The core of their innovation lies in the unique O2-DDR technology platform, which manages oxidative stress, oxidative DNA damage, and the DNA Damage Response (DDR) in cells. Thi...

Tagger

B2BPharmaceuticalsProfessional ServicesTechnologyWhite Collar

Nøkkelord

BiotechClinical DevelopmentDDRDrug DiscoveryFibrosisOncologyOxidative Stress

Teknologier i bruk

jQueryVimeoWordPressCookiebotYouTubeGoogle Analytics

Bedriftsinformasjon

Bransje
Annan naturvetenskaplig och teknisk forskning och utveckling
Juridisk form
Aktiebolag
MVA-nummer
SE556979799501

Beslutningstakere

9 kontakter i Funnelfeedr

Ulrika Warpman Berglund

CEO

@oxcia.com+46732XXXXXX

Monika Vedin

Business strategy & Communication Director

@oxcia.com

Christina Kalderén

Preclinical Director

@oxcia.com

Austin Smith

Chief Medical Officer

@oxcia.com

Ingvar Karlsson

Member of the Board

@oxcia.com

Thomas Helleday

Member of the Board

@oxcia.com

Eva Sjökvist Saers

Chairman of the board

@saers.com

Håkan Nordlander

Head Administration and Accounting

@oxcia.com

Gustaf Eriksson

Sales and Marketing Manager

@atek.nu+46708XXXXXX

Lignende bedrifter

20 lignende bedrifter i Funnelfeedr

Utforsk mer

Spørsmål om DiaBridge AB

Vil du se Funnelfeedr i aksjon?

Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.

Book en demo